Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News

February 2005

Nexa Orthopedics, Inc. and HealthpointCapital Announce Purchase of Futura Biomedical, L.L.C. BY EDITOR, FEBRUARY 23, 2005

We sent the following press release out today. Nexa Orthopedics, Inc. and HealthpointCapital Announce Purchase of Futura Biomedical, L.L.C. Nexa Orthopedics, Inc. is focused on developing innovative products to meet the unmet clinical needs of the extremity surgeon. New York,... more

FIVE HOT AAOS Sessions Plus 20 others worth a close look BY EDITOR, FEBRUARY 22, 2005

Overwhelmed with all the education opportunities? Join the club. Good news for you, though - the HealthpointCapital research team has whittled down the program to 26 of the most controversial and best-hosted side sessions. Minimally Invasive Breaks Out Every year... more

Spine Segment Outlook BY JOHN MCCORMICK, FEBRUARY 22, 2005

HealthpointCapital, LLC research has initiated a new program of making our market forecasts of the several orthopedic medical device segments available to our subscribers. This article, the first of a series, summarizes our spine market forecast which comes from our... more

Notes on the New FDA Oversight Board and Pending Lester Crawford Nomination BY JOHN MCCORMICK, FEBRUARY 14, 2005

This morning, newly sworn in House and Human Service Secretary Mike Leavitt announced the creation of a new independent Drug Safety Oversight Board to monitor FDA-approved medicines once they are on the market. The Board will continually update physicians and... more

Genzyme Acquires Verigen AG BY JOHN MCCORMICK, FEBRUARY 14, 2005

On Tuesday of last week, Genzyme Corporation (Nasdaq: GENZ) announced another foray into the world of cartilage repair with the acquisition of Germany's Verigen AG. Founded only in 1999, Verigen has been selling a proprietary cell therapy system for cartilage... more

2005 American Academy of Orthopaedic Surgeons (AAOS) Preview BY JOHN CHOPACK, FEBRUARY 14, 2005

It's here again, the annual AAOS conference. Thousands are ready to descend on Washington, D.C. the week of February 21st to learn of new surgical techniques, new products and to develop business and relationships. While it is hard to predict... more

Kyphon Reports 2004 Results: Brief Thoughts on the Size of the VCF Market BY JOHN MCCORMICK, FEBRUARY 14, 2005

Last week, Kyphon Inc. (Nasdaq: KYPH) met or exceeded analysts' expectations and announced net sales of $62.4 million for 4Q:04, an increase of 57% over the $39.7 million in net sales reported in 4Q:03 Earnings per fully-diluted share for 4Q:04... more

Millenium Biologix Released 3Q:05 Results BY HUYEN NGUYEN, FEBRUARY 14, 2005

Last week, Canadian's Millenium Biologix Corp. (TSX: MBC), a biomedical company that develops and supplies minimally invasive devices and skeletal tissue regeneration products, reported its 3Q:05 and its twelve months results for December 31, 2004. Millenium Biologix Corporation is the... more

Wright Medical (WMGI:NASDAQ) Reports 4Q:04 Financials BY JOHN CHOPACK, FEBRUARY 14, 2005

Wright reported both 4Q:04 and year-end 2004 financials on Thursday evening. 4Q:04 revenues totaled $77.7 million a 13% increase over 4Q:03 revenues and at the upper end of management's previous guidance of revenues of $76-$78 million. Revenues for the year... more

Smith & Nephew (SNN:NYSE) Reports 4Q:04 & 2004 Financials BY JOHN CHOPACK, FEBRUARY 7, 2005

After a strong report from Zimmer earlier in the week, Smith & Nephew followed suit on Thursday. SNN reported revenues totaled £332 million for the 4Q:04 which was a 14% increase over the 4Q:03 on a constant currency basis. Earnings-per-share... more

Synthes Reported Fourth-Quarter and Fiscal Year 2004 Earnings Results BY HUYEN NGUYEN, FEBRUARY 7, 2005

Synthes, Inc. (SYST.VX), a worldwide maker, developer and distributor of orthopedic trauma implants, biological devices and spinal hardware, reported financial results for fourth-quarter and fiscal year 2004 on January 20/2005. SYST reported sales for 4Q:04 at $469.4 million, an increase... more

Zimmer (ZMH:NYSE) Beats the Street by $0.07 in EPS and $18 Million in Revenues; Stock Gains 11% on Tuesday. BY JOHN CHOPACK, FEBRUARY 7, 2005

After Stryker and DePuy reported somewhat modest financial reports two weeks ago, it seemed like many industry analysts and experts were talking of a potential slowdown in orthopedic growth. Then Zimmer reported revenues of $800 million for the 4Q:04 which... more


Complete Archive